| Prev Close | 22.52 |
| Open | 22.58 |
| Day Low/High | 22.21 / 22.74 |
| 52 Wk Low/High | 20.58 / 33.11 |
| Volume | 66.36K |
| Avg Volume | 297.60K |
| Exchange | NASDAQ |
| Shares Outstanding | 33.22M |
| Market Cap | 753.72M |
| EPS | -0.10 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today...
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...
On Wednesday, February 14, 2018, Cardiovascular Systems' (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the LEERINK Partners 7 th Annual Global Healthcare Conference at 10:30 a.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced...
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cardiovascular Systems, Inc , where a total volume of 1,104 contracts has been traded thus far today, a contract volume which is representative of approximately 110,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50.9% of CSII's average daily trading volume over the past month, of 217,075 shares.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today announced that it has...
Investors in Cardiovascular Systems, Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CSII options chain for the new February 16th contracts and identified one put and one call contract of particular interest.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today...
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 second-quarter conference call on Wednesday, February 7, 2018, at 3:45 p.
Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that it is investigating whether certain officers and directors of Cardiovascular...
Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.
Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain officers and directors of Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.
In trading on Monday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $28.76, changing hands as low as $28.15 per share. Cardiovascular Systems, Inc shares are currently trading down about 7.2% on the day.
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter...
A new sub-analysis from the landmark LIBERTY 360° study, sponsored by Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today released one-year data from its LIBERTY 360° clinical study in a late-breaking presentation at the 2017 Amputation Prevention Symposium (AMP) in Chicago.
Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, August 2, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $52.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2017 fourth-quarter conference call on Wednesday, August 2, 2017, at 3:45 p.
On Wednesday, June 21, 2017, Cardiovascular Systems' (NASDAQ: CSII) Chief Financial Officer, Larry Betterley, will present at the JMP Securities Life Sciences Conference at 11:30 a.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATRO, BLL, CCE, CSII, EGN, EMR, HCI, IMPV, K, MANT, MLCO, MX, OI, RDS.A, RDS.B, TPRE, USCR, WMC Downgrades: CCO, CLF, GCAP, INCY, KMPR, OMCL, OMI, SHEN, SWIR, UEPS Initiations: ORMP Read on to get TheStreet Quant Ratings' detailed report:
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced that the U.
Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, May 3, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $52.
In recent trading, shares of Cardiovascular Systems, Inc have crossed above the average analyst 12-month target price of $30.50, changing hands for $30.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
PAD is the biggest disease that most people have never heard about.
PAD is the biggest disease that most people have never heard about.
